Oman Pharmaceuticals and Healthcare Report Q3 2014

Date: May 14, 2014
Pages: 103
Price:
US$ 1,295.00
Publisher: Business Monitor International
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O611450F1BFEN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Oman's strong demand for patented innovative drugs, driven by its traditional wealth, especially among the sizeable expatriate community, will continue to attract multinational company investment. Although a relatively small market in comparison with the rest of the Gulf Cooperation Council, high growth rate estimates over the next decade, the country's growing and ageing population and a rapid increase in non-communicable diseases provide opportunities for high returns on investment.

Headline Expenditure Projections
  • Pharmaceuticals: OMR175mn (USD455mn) in 2013 to OMR192mn (USD505mn) in 2014; 9.5% in local currency terms and 11.0% in US dollar terms. Forecast broadly in line with Q214.
  • Healthcare: OMR781mn (USD2.03bn) in 2013 to OMR860mn (USD2.26bn) in 2014; +10.1% in local currency terms and +11.5 in US dollar terms. Forecast revised slightly upwards due to macroeconomic changes.
Risk/Reward Rating

Oman has limited longer-term commercial potential due to its small population and the fact that the government is responsible for the bulk of healthcare costs, which will increase the need for cost containment in the coming years. In Q314, Oman's Pharmaceutical Risk/Reward Rating (RRR) scores 49.3 out of 100, which has seen the country move up two positions to 9th in the Middle East and Africa matrix. This is on account of receiving a higher score for its pharmaceutical market size (an industry rewards component) and economic diligence (a country rewards component).
BMI Industry View
SWOT
Political
Economic
Business Environment
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Oman 2010-2018)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2010-2018)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2010-2018)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2010-2018)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Oman 2010-2018)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Oman 2010-2018)
Generic Drug Market Forecast
  Table: Generics Drug Market Indicators, Historical Data And Forecasts (Oman 2010-2018)
OTC Medicine Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Oman 2010-2018)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecast (Oman 2012-2018)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Oman 2012-2018)
Other Healthcare Data
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Outlook
Industry Risk Reward Ratings
Middle East & Africa
Oman Risk/Reward Ratings
Rewards
Risks
Market Overview
Industry Trends And Developments
Industry Trends And Developments
Epidemiology
Communicable Diseases
Non-Communicable Diseases
Healthcare Sector
Public Healthcare Sector Developments
Private Healthcare Sector Developments
  Table: Number Of Health Centres In Oman By Region
  Table: Number And Type Of Health Institutions In Oman In 2011
Healthcare Insurance
Telemedicine
Medical Tourism
Research And Development
Clinical Trials
Regulatory Development
Regulatory Developments
Intellectual Property Regime
Regional Harmonisation
Pricing And Reimbursement Regime
Competitive Landscape
Domestic Pharmaceutical Industry
Foreign Pharmaceutical Industry
Pharmaceutical Distribution
Company Profile
Zynova/Oman Pharmaceutical Products Company
National Pharmaceutical Industries (NPI)
Novartis
GlaxoSmithKline
Sanofi
Johnson & Johnson
Demographic Forecast
  Table: Oman's Population By Age Group, 1990-2020 ('000)
  Table: Oman's Population By Age Group, 1990-2020 (% of total)
  Table: Oman's Key Population Ratios, 1990-2020
  Table: Oman's Rural And Urban Population, 1990-2020
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Ratings Methodology
Ratings Overview
  Table: Pharmaceutical Risk/Reward Ratings Indicators
Indicator Weightings
Oman Pharmaceuticals and Healthcare Report Q4 2013 US$ 1,295.00 Sep, 2013 · 97 pages
Oman Pharmaceuticals and Healthcare Report Q1 2014 US$ 1,295.00 Nov, 2013 · 102 pages

Ask Your Question

Oman Pharmaceuticals and Healthcare Report Q3 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: